This phase II/III trial is comparing conventional radiotherapy and stereotactic radiotherapy in patients with spinal metastases.
This trial is treating patients with spinal metastases.
This is a radiotherapy trial.
You may be able to join this trial if:
- Your cancer has spread to other parts of the body.
You may be excluded from this trial if:
- You have a certain disease or psychological condition.
- You have had certain treatments, surgical procedures or drugs.
Clinical trials have complex eligibility criteria - talk to your doctor about your interest in this trial.
Clinical Summary Read More
Use the hyperlinks, where available to access additional clinical trial information.
A Randomized Phase II/III Study Comparing Stereotactic Body Radiotherapy(SBRT) Versus Conventional Palliative Radiotherapy (CRT) for Patients With Spinal Metastases
Canadian Cancer Trials Group
Patients in this trial will be randomised to receive Standard Conventional Radiotherapy (CRT) 20 Gy in 5 fractions OR Stereotactic Body Radiotherapy (SBRT) 24 Gy in 2 fractions.
Recruiting Hospitals Read More
Not Recruiting Hospitals Read More